About Tesamorelin
Tesamorelin is a 44-amino-acid GHRH analog FDA-approved in 2010 for HIV-associated lipodystrophy. Raises IGF-1 by 181 mcg/L over 26 weeks at 2 mg daily and reduces visceral fat by 15.7%.
Reported benefits
- Raises IGF-1 by 181 mcg/L over 26 weeks at 2 mg daily
- Reduces visceral adipose tissue by 15.7% in FDA pivotal trial
- Adds 1.7 kg lean mass over 12 weeks in trained adults
Research citations
- Falutz et al. 2010 - NEJM
- Stanley et al. 2014 - JAMA
How Tesamorelin fits the category
Tesamorelin sits inside the Best Peptides for Muscle Growth category. For the full ranking and head-to-head comparisons, read Best Peptides for Muscle Growth.

